Haematology Books

244 products


  • Hemostasis Laboratory Yearbook: Volume 1

    Nova Science Publishers Inc Hemostasis Laboratory Yearbook: Volume 1

    1 in stock

    Book SynopsisHemostasis (coagulation and fibrinolysis) is of importance in a broad range of medical disciplines. A high-quality hemostasis diagnosis enables a good therapy, which can be rather complicated without laboratory help. This yearbook gathers important contributions in this field and presents them in a coherent and logical format.

    1 in stock

    £155.99

  • Handbook of Hematology Research: Hemorheology,

    Nova Science Publishers Inc Handbook of Hematology Research: Hemorheology,

    1 in stock

    Book SynopsisHaematology is the branch of medicine that deals with diseases of the blood and blood-forming organs. Haemophilia is one of the most important diseases of haematology research. Medically, the classical treatment of haemophilia is transfusion therapy, which has been widely used for years. However, the transfusion can bring several complications for haemophilic patients, such as the onset of blood borne infectious diseases. This book discusses such diseases, as well as the new trend in blood product safety management. Until present, the new modality of gene therapy is the hope for successfully treating haemophilia. The authors of this book briefly review and discuss this new haemophilia treatment. In addition to examining the aetiology, pathogenesis and treatment of haemophilia, the factors involved in the activation of blood coagulation are examined as well. Other chapters in this book explore the immune responses and induction of immune tolerance to FVIII/FIX in haemophilia gene transfer, the haemostatic changes in complicated pregnancy states like preeclampsia and pregnancy-induced hypertension, a review of the new routine parameters for diagnosis of the early phases of pathologic disseminated intravascular coagulation (PDIC), and the quantitative and qualitative congenital plasminogen defects of the fibrinolytic system.

    1 in stock

    £232.49

  • Cell Determination During Hematopoiesis

    Nova Science Publishers Inc Cell Determination During Hematopoiesis

    1 in stock

    Book SynopsisFor many years the mammalian blood cell system has provided cell biologists and haematologists with one of the best experimental models in which to unravel how one stem cell -- the hematopoietic stem cell -- gives rise to many different types of progeny. Numerous models of lineage relationships have emerged, but the most influential of these, in which differentiating cells undergo a series of binary choices, has been increasingly challenged in recent years -- to the extent that the accumulation of new findings recently culminated in a Nature commentary suggesting that "the latest research will necessitate revision of textbook accounts". This book brings together contributions from many leading experts in the field of blood cell development who each discuss both the overall process of hematopoiesis and the origins and development of each of the cells of the blood and immune systems. It describes how new molecular, cellular and -- particularly -- transgenic tools are helping us understand the processes that control the lineage fates of hematopoietic stem and progenitor cells and how lineage-committed progeny develop along particular maturation pathways.

    1 in stock

    £86.99

  • Hemostasis Laboratory Yearbook: Volume 2

    Nova Science Publishers Inc Hemostasis Laboratory Yearbook: Volume 2

    2 in stock

    Book Synopsis

    2 in stock

    £146.24

  • Hemostasis Laboratory Yearbook: Volume 3

    Nova Science Publishers Inc Hemostasis Laboratory Yearbook: Volume 3

    2 in stock

    Book Synopsis

    2 in stock

    £146.24

  • Hemostasis Laboratory Yearbook: Volume 4

    Nova Science Publishers Inc Hemostasis Laboratory Yearbook: Volume 4

    1 in stock

    Book Synopsis

    1 in stock

    £146.24

  • Hemostasis Laboratory Yearbook: Volume 5

    Nova Science Publishers Inc Hemostasis Laboratory Yearbook: Volume 5

    1 in stock

    Book Synopsis

    1 in stock

    £146.24

  • von Willebrand Disease: Diagnosis & Management

    Nova Science Publishers Inc von Willebrand Disease: Diagnosis & Management

    1 in stock

    Book Synopsisvon Willebrand disease (VWD) is an inherited bleeding disorder that is caused by deficiency or dysfunction of von Willebrand factor (VWF), a plasma protein that mediates the initial adhesion of platelets at sites of vascular injury and also binds and stabilizes blood clotting factor VIII (FVIII) in the circulation. This book examines the need for more information on VWD prevalence and the relationship between low VWF levels of bleeding symptoms or risk and improving clinical and laboratory diagnostic tools.

    1 in stock

    £106.49

  • Trends in National Blood Collection & Cord Blood

    Nova Science Publishers Inc Trends in National Blood Collection & Cord Blood

    1 in stock

    Book SynopsisThis book examines the 2009 National Blood Collection and Utilization Survey Report which provides data for national bio-vigilance safety monitoring; and monitors business practices in the blood collection, transfusion medicine, and cellular therapy communities. Also discussed are important trends in U.S. blood supply collection; blood transfusion practices and National Cord Blood Inventory practices for increasing availability for transplants and related challenges.

    1 in stock

    £106.49

  • Hematomas: Types, Treatments & Health Risks

    Nova Science Publishers Inc Hematomas: Types, Treatments & Health Risks

    1 in stock

    Book SynopsisThis book presents topical research in the study of the types, treatments and health risks associated with hematomas. Topics discussed include the physiotherapeutic treatments of hematomas; cerebrospinal hematoma; infected hematomas; the etiology of pelvic hematomas; intracranial hematomas in pediatric patients; massive retroperitoneal hematoma following vaginal correction of vault prolapse and retropharyngeal hematomas.

    1 in stock

    £106.49

  • Sickle Cell Disease: A New Vision for an Old

    Nova Science Publishers Inc Sickle Cell Disease: A New Vision for an Old

    1 in stock

    Book SynopsisSickle cell hemoglobin (HbS) is the result of a single nucleotide change (GAG → GTG) in the β-globin gene, where valine replaces glutamic acid at the sixth amino acid position in the β-globin chain. Sickle cell disease is a growing global health problem. The World Health Organization has estimated that 7% of the world population has the mutation and 300,000400,000 affected children are born every year. The disease progresses towards a severe chronic hemolytic anemia, and it shows a heterogeneous clinical course, related with different genetic factors. Despite the fact that all subjects with sickle cell disease (SCD) have the same single base pair mutation in the DNA, we further confirmed here that the severity of the clinical and hematological manifestations is extremely variable. Increasing evidence has indicated a role of oxidative stress in the vascular pathophysiology of SCD. The vascular endothelium is central to disease pathogenesis because it displays adhesion molecules for blood cells, balances procoagulant and anticoagulant properties of the vessel wall and regulates vascular homeostasis by synthesizing vasoconstricting and vasodilating substances. In addition, recent studies support the existence of a hyperoxidative status in SCD patients that may account, at least in part, for the clinical manifestations of these patients. Moreover, SCD patients with mild clinical outcomes were associated with low oxidative status, whereas high oxidative stress was related to severe phenotypes. Thus, the use of oxidative stress biomarkers may be important in the evaluation of the clinical condition of SCD patients, whereas the use of therapies to improve their redox status and increase NO bioavailability would be beneficial to reduce the severity of sickle disease. The global burden of SCD is now significantly increased and, thus, it is currently a public health problem around the world. This disease has passed from being a problem of the developing countries to affect many people in developed countries. This book summarizes the current epidemiology status and the latest discoveries in the pathophysiology of SCD, and the potential therapies that may improve the clinical course of this disease.

    1 in stock

    £146.24

  • Deep Vein Thrombosis: Symptoms, Diagnosis &

    Nova Science Publishers Inc Deep Vein Thrombosis: Symptoms, Diagnosis &

    1 in stock

    Book SynopsisDeep venous thrombosis (DVT) is the third most common cardiovascular disease. Two-thirds of patients with DVT are first episodes, and the remainders are recurrences. Pulmonary embolism is the most common complication of DVT. And now, DVT and pulmonary are considered two spectra of the same disease, namely venous thromboembolism (VTE). This book provides a comprehensive review of current diagnosis and treatment of DVT. This book includes chapters on clinical approaches in DVT, VTE and cancer, prevention of DVT in neurological surgery, combination of pretest clinical probability score and different D-dimer cut-off value for exclusion of VTE, ambulatory therapy for DVT, management of DVT with oral anticoagulant, surgical intervention for acute DVT, and recent multi-centre survey of DVT from Japan. In this book, the mechanisms of VTE, diagnostic strategy of DVT, various treatment options for DVT, and prevention of VTE are discussed.

    1 in stock

    £86.99

  • Myelodysplastic Syndromes: From Pathogenesis to

    Nova Science Publishers Inc Myelodysplastic Syndromes: From Pathogenesis to

    1 in stock

    Book SynopsisIn spite of tremendous advances in the field, the current understanding of pathogenesis of myelodysplastic syndromes (MDS) remains limited. Furthermore, the correct diagnosis and effective therapy of this heterogeneous group of clonal haematological disorders represent a common challenge in daily practice of haematology. This book provides a thorough, up-to-date, and comprehensive review of different aspects of MDS. Chapters are written by selected investigators and clinicians with specific expertise and track record of research in the field. Of particular interest, the clinical chapters provide a practical approach to the treatment of patients with different manifestations of the disease. This book would be a useful asset to researchers in the field as well as haematologists in practice. Other health care members such as haematology fellows in training, residents, medical students and nurses will also find this book helpful for better understanding of the disease and clinical management of patients with MDS.

    1 in stock

    £206.24

  • Cord Blood: Banks & Banking, Ethical Issues &

    Nova Science Publishers Inc Cord Blood: Banks & Banking, Ethical Issues &

    1 in stock

    Book SynopsisIn this book, the authors discuss cord blood banks and banking, the ethical issues involved and the risks and benefits. Topics include the virological risks and benefits of cord blood banking; mesenchymal stem cells and their role in regenerative medicine applications; osteogenic potential of human umbilical cord-derived mesenchymal stromal cells; public versus private cord blood banking; CCR5 deficient cord blood as a means of treatment for HIV-1 infection; and the therapeutic use of umbilical cord blood.

    1 in stock

    £119.99

  • Quality Management in Transfusion Medicine

    Nova Science Publishers Inc Quality Management in Transfusion Medicine

    1 in stock

    Book SynopsisTransfusion Medicine is a key part of modern health care. It bridges the healthy community with the bedside in hospitals. It is the responsibility of the national blood program to provide an adequate supply of blood for all patients requiring transfusion, and to ensure the quality of blood and blood products for clinical use and the in-hospital transfusion chain. All products must be safe, clinically effective and of appropriate, and consistent quality. Every blood transfusion service, whether serving in a resource restricted environment or in an advanced ambience, should develop an effective quality (QS) and quality management system (QMS) to ensure the implementation of these strategies from vein to vein. The quality system and its management should cover all aspects of its activities and ensure full traceability (hemovigilance), from the motivation, mobilisation and selection of blood donors to the transfusion of blood and blood products to patients. It should also reflect the structure, needs and capabilities of the procurement establishments, as well as the needs of the hospitals and patients that it serves. Management commitment and support are essential for the development, implementation and monitoring of a national quality system and quality management system in order to ensure change management and continuous quality improvement. All staff should understand the importance of quality and the consequences of failure in the quality system (error management and cost effectiveness).

    1 in stock

    £245.99

  • Disseminated Intravascular Coagulation (DIC):

    Nova Science Publishers Inc Disseminated Intravascular Coagulation (DIC):

    2 in stock

    Book SynopsisDisseminated Intravascular Coagulation is a devastating syndrome characterised by the systemic activation of widespread activation of the coagulation cascade and thrombosis, which may result in severe bleeding and may lead to organ failure. Recent studies have shown that the incidence of DIC is decreasing, especially in men. Despite the improvements in health care delivery, the morbidity and mortality due to DIC remains very high. Early diagnosis and accurate prognosis are important in improving the outcomes of patients with DIC. However, there is a lack of a gold standard diagnostic test to diagnose DIC and there is a scarcity of treatment or management strategies. Therefore, an understanding of the pathophysiology, ability to diagnose the DIC syndrome and treat it early, is the key. This book provides an important timely update on the clinical manifestations, important risk factors, and treatment strategies for DIC, and provides in-depth information on pathophysiological aspects and various diagnostic scores used to diagnose DIC. Furthermore, we focused on certain important factors related to DIC such as sepsis, chronic DIC in cancer patients, coagulopathy of liver disorders vs. DIC, and DIC in urological malignancies. In addition, this book provides evidence from an important study determining the predictors influencing the hospital mortality rates of critically ill patients with DIC. This book offers a wide scope of information for physicians in all fields, whether they are intensivists, primary care physicians or oncologists, this will be an important source for identifying the DIC syndrome early, and the appropriate steps to improve patient outcomes will be taken sooner.

    2 in stock

    £92.99

  • Venous Thrombosis: Risk Factors, Management &

    Nova Science Publishers Inc Venous Thrombosis: Risk Factors, Management &

    1 in stock

    Book SynopsisThrombophilias can be defined as a group of inherited or acquired disorders that increase the risk of developing thrombosis. Venous thromboembolism (VT) is considered a multifactorial disease produced by a sum of risk factors that predispose to the thrombotic event. This predisposition includes genetic and acquired defects. Thrombosis can occur in any section of the venous system, but commonly manifests as deep vein thrombosis of the leg and pulmonary embolism. Major complications of venous thrombosis are a disabling post-thrombotic syndrome, pulmonary hypertension, and sudden death duo to a pulmonary embolism and therefore, it poses a burden on health economy. Venous thrombosis is a common clinical challenge for doctors of all disciplines, as it is a complex multicausal disease. This books discusses in further detail the many complications and risk factors caused by venous thrombosis.

    1 in stock

    £122.99

  • Deep-Vein Thrombosis: Risk Factors, Treatment &

    Nova Science Publishers Inc Deep-Vein Thrombosis: Risk Factors, Treatment &

    1 in stock

    Book SynopsisInferior Vena Cava (IVC) filters have become an important part of deep venous thrombosis and pulmonary embolism treatment and prevention. With the advent of retrievable filters a new era of IVC instrumentation has been initiated. This book will begin to review the history of IVC filtration, indications for permanent and temporary filter use and filter use in special populations such as the pregnant patient or those with upper extremity venous thrombosis. The authors also review the technical aspects of filter placement and retrieval and discuss immediate and long-term complications from IVC filters. The book will also continue to discuss how acute spinal cord injury provides risks for developing deep vein thrombosis; and discuss the efficacy and safety of novel oral anticoagulants for venous thromboembolisms.

    1 in stock

    £73.49

  • Plasmapheresis & Intravenous Immunoglobin:

    Nova Science Publishers Inc Plasmapheresis & Intravenous Immunoglobin:

    1 in stock

    Book SynopsisPlasmapheresis is a therapeutic tool used to treat a wide range of disease processes, and in which the priority aim is to ensure sufficient plasma exchange to reduce or eliminate symptoms resulting from the action of pathogenic elements vehiculised in the plasma. Scientific selective apheresis with principles of evidence-based medicine involves the application of one of the oldest therapeutic modalities (bleeding), widely used between the fourth century B.C. and the second industrial revolution. This book provides information on the use of plasmapheresis during pregnancy; therapeutic use of autologous plasma for the treatment of dry eye disease; and therapeutic plasma exchange in the neurological setting. It also discusses intravenous immunoglobulins. During the past decades intravenous immunoglobulins (IVIG) have gained more and more popularity for the treatment of a wide range of diseases and conditions. This treatment is extensively used in immune deficits, autoimmune thrombocytopenia, Kawasaki''s disease, for the prevention of infectious complications due to hypogammaglobulinaemia secondary to myeloma, chronic lymphatic leukaemia and post-bone marrow and stem cell transplantation, in Guillain-Barre syndrome, etc. IV-Ig is obtained from the plasma of healthy blood donors and contains normal, polyclonal, polyspecific immunoglobins (Ig), mostly consisting of intact IgG. These antibodies are directed against non-self-antigens, self-antigens (natural autoantibodies), and other antibodies (idiotypic antibodies). The administration of intravenous immunoglobulin (IVIG) is generally safe and well tolerated. However, the treatment of autoimmune disorders usually requires high dose therapy (1-2 g/kg) that may result in a greater frequency of side effects and adverse events. This book discusses several topics including the clinical application of intravenous immunoglobulins in autoimmune mediated ocular inflammatory diseases; complications of intravenous immunoglobulin therapy; clinical uses; and side effects.

    1 in stock

    £152.99

  • Thalassemia: Causes, Treatment Options &

    Nova Science Publishers Inc Thalassemia: Causes, Treatment Options &

    1 in stock

    Book SynopsisThalassemia is one of the most common genetic disorders worldwide and presents major public health and social challenges in areas of high incidence. The frequency of this disorder varies considerably with geographic locations and racial groups. Thalassemia refers to a group of inherited hemolytic anemia disorders that involve defects in the synthesis of hemoglobin α- or β-polypeptide chains. It leads to decreased hemoglobin production and hypochromic microcytic anemia associated with erythrocyte dysplasia and destruction. Homozygous β-thalassemia (also known as thalassemia major, Cooley''s anemia, or Mediterranean anemia) is associated with the most severe signs and symptoms. Thalassemia major (TM) is a life-threatening condition that commonly manifests during early infancy, after which progressive pallor, severe anemia, and failure to thrive are common. Children with TM often develop feeding problems, recurrent fever, bleeding tendencies (especially epistaxis), susceptibility to infection, pathologic fractures of long bones and vertebrae, endocrine abnormalities, splenomegaly, lack of sexual maturation, and growth retardation. This book discusses cures and treatments available for thalassemia, as well as the causes and the type of long-term health outcomes it may cause.

    1 in stock

    £182.99

  • Myeloproliferative Disorders: Symptoms, Risk

    Nova Science Publishers Inc Myeloproliferative Disorders: Symptoms, Risk

    1 in stock

    Book SynopsisMyeloproliferative disorders are a group of clonal haematological neoplasms characterised by proliferation of one or more cells of myeloid lineage. They are the result of acquired mutations in the progenitor cell leading to hyper proliferation or neoplastic expansion of more mature forms of myeloid cells. Cells retain their functional ability with some degree of defects and also lead to suppression of normal stem cells. The most common type of Myeloproliferative Neoplasms (MPN) can broadly be classified into BCR ABL positive (Chronic Myelogenous Leukemia) and BCR ABL negative Disorders (Polycythemia Vera PV, Essential Thrombocytosis ET and Primary Myelofibrosis PMF). There are other rare types which have relatively low incidence like chronic neutrophilic leukemia, chronic eosinophilic leukemia, systemic mastocytosis and myeloproliferative neoplasms unclassifiable. These are the indolent type of haematological malignancies associated with marrow hypercellularity and organomegaly, with gradual progression to myelofibrosis or transformation to acute leukemias. During the dormant course of the BCR ABL negative MPN, they are more prone to thrombo-hemorrhagic complications and the treatment strategy is directed mostly to prevent complications. The past decade; therapies for BCR ABL positive disease (CML) have been a milestone achievement in keeping the disease in remission for many years, preventing major complications and halting the progression of the disease. This book discusses the classification, diagnosis and treatment of myeloproliferative diseases and provides insight on the symptoms and risk factors involved in the diseases.

    1 in stock

    £86.99

  • Thrombocytopenia: Epidemiology, Potential

    Nova Science Publishers Inc Thrombocytopenia: Epidemiology, Potential

    2 in stock

    Book SynopsisDecreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the different diagnosis of thrombocytopenia; heparin-induced thrombocytopenia; and thrombocytopenia in dengue.

    2 in stock

    £152.99

  • Anemia: Prevalence, Risk Factors & Management

    Nova Science Publishers Inc Anemia: Prevalence, Risk Factors & Management

    1 in stock

    Book SynopsisAnaemia is defined as the decrease in haemoglobin from normal values either by loss of red blood cells or deficit in production or both. Haemoglobin is the major transporter of oxygen. The variation in haemoglobin is therefore a factor in determining the cardiac output. This book begins by discussing the effects anaemia has on heart diseases. The book then continues to discuss the influence of iron deficiency anaemia and recovery on oxidative/antioxidant status; influence of iron deficiency anaemia on bone metabolism; sickle cell anaemia; anaemia in myelodysplastic syndromes; transfusion in chronic anaemia; the prevalence, risk factors and management with a focus on chronic kidney disease; strategy for treating anaemia in chronic kidney disease patients from the standpoint of iron utility; and parasitic anaemia.

    1 in stock

    £152.99

  • Neutropenia: Causes, Signs, Symptoms & Treatment

    Nova Science Publishers Inc Neutropenia: Causes, Signs, Symptoms & Treatment

    1 in stock

    Book SynopsisThis book discusses different aspects of neutropenia including drug-induced neutropenia, which is quite common, and neutropenia in chemotherapy-treated patients. The authors offer an all-encompassing approach to the pathobiology and treatment of neutropenic disorders. This book reviews current information concerning neutropenia. There have been significant advances in medicine; however, bacterial infections continue to contribute significantly to morbidity and mortality in patients with neutropenia particularly cancer patients who develop chemotherapy-induced neutropenia. In this setting, it is important to understand pathophysiology of neutropenia and have a logical approach in diagnosis and treatment of neutropenia. Gathering all this information in one book will be of immense benefit for healthcare workers including physicians, pharmacists, physician assistants, nurse practitioners and nurses and this in turn will help them improve the care of their patients. It will also be of benefit for pharmacists as a source of clinical and pharmacological knowledge. For researchers undertaking research in the field of hemato-oncology or pharmacology, this will be a useful starting point for reviewing the literature. The editors have tried to allow information in book chapters to show different aspects and various view points on related issues.

    1 in stock

    £113.59

  • Sickle Cell Disease: Genetics, Management &

    Nova Science Publishers Inc Sickle Cell Disease: Genetics, Management &

    1 in stock

    Book SynopsisSickle cell disease (SCD) is a genetic disorder caused by an abnormality of hemoglobin. The disease is characterized by a chronic hemolytic anemia. The search for affordable and accessible medicines mainly from plants and having various modes of actions for managing SCD is a priority in Africa where the disease is endemic. The first chapter in this book reviews children with Sickle Cell Disease (SCD). The authors also present their research that shows that clinically, children with SCD behave differently regarding their genetics. The second chapter gives an overview of the current progress in research in calcium handling in red blood cells of sickle cell disease patients, followed by an outlook into the potential use of blockers of the cation channels for therapy of SCD patients. The third chapter reviews and validates the pharmacological relevance of "Gardenia ternifolia" and sustains the use of this herbal medicine in the management of SCD in traditional medical systems. The fourth chapter reviews the search and the development of antisickling herbal drugs in Africa, where Sickle cell disease (SCD) is an endemic. The last chapter reviews SCD and its impact on sexual functioning as well as relationship dynamics. Conclusions support the importance of social support and its far-reaching impact into the coping mechanisms of patients with chronic illness as well as quality of life.

    1 in stock

    £127.99

  • Clotting Disorders: Symptoms, Diagnosis &

    Nova Science Publishers Inc Clotting Disorders: Symptoms, Diagnosis &

    1 in stock

    Book SynopsisCoagulopathy (also called clotting disorder and bleeding disorder) is a condition in which the blood''s ability to clot (coagulate) is impaired. Acquired hemophilia is a rare disorder characterized by spontaneous bleeding in a patient with no previous personal or family hemorrhagic history. The first chapter explores the challenges associated with this disease, its unfamiliarity often causing a delay in diagnosis and therapeutic approaches. The second chapter focuses on lower gastrointestinal bleeding (LGIB) in children, describing the epidemiology, etiology and clinical management. The third chapter reviews the pathogenesis, risk factors and treatment strategies of coagulopathy in patients with craniocerebral injury. The next article examines Vitamin B12 with its four cobalamin vitamers, which often play a role in coagulation. The next chapter starts with a description of the methodology of viscoelastic hemostatic assay, followed by a review of literature on the utilization of thrombelastography (TEG) or rotational thromboelastometry (ROTEM). Finally, the role of TEG and ROTEM to monitor or guide prophylaxis/treatment of thromboembolic events and the limitations of using them to detect hypercoagulability and identify patients with increased risks for thromboembolic complications are discussed. The final chapter of this book focuses on the use of fresh frozen plasma (FFP) in patients who are not actively bleeding, critically questions these assumptions in the context of pre-procedural administration of FFP, and also examines why carrying out high quality trails in this area has been so problematic.

    1 in stock

    £127.99

  • A manual for blood conservation

    TFM Publishing Ltd A manual for blood conservation

    4 in stock

    Book SynopsisA multi-disciplinary team approach within this new book which evaluates the current state-of-play with regard to blood conservation, including a fresh look at the evidence. Contents will cover the Supply and Demand issues; why/how changes have occurred; a historical overview; transfusion transmitted diseases; changing demographics and the projected impact on blood supplies; considerations for transfusion practice; surgical peri-operative techniques; medical management; risk management issues; the role of the Hospital Transfusion Team; educational issues; National Reports/Edicts; clinical networks in blood transfusion.

    4 in stock

    £22.50

  • All Blood Counts: A manual for blood conservation

    TFM Publishing Ltd All Blood Counts: A manual for blood conservation

    1 in stock

    Book SynopsisThis book gathers together the collected wisdom of an experienced group of practitioners from the world of blood conservation including surgeons, anaesthetists, haematologists, transfusion specialists, microbiologists, and legal advisors. Topics included are: an historical overview, transfusion-transmitted diseases, changing demographics and the projected impact on blood supplies, who needs transfusion, practicalities and tips - how to do it, the laboratory perspective, haemodilution, intra-operative cell salvage, surgical methods to minimise blood loss, anaesthetic methods to minimise blood loss, pharmacological methods to minimise blood loss, postoperative salvage, postoperative haemoglobin, cancer patients, patient consent and refusal, trauma management, patient ID and documentation, audit/clinical governance, the role of the Hospital Transfusion Team, education, national reports including European Directives, further information. Additional chapters will include pre-operative blood management, near-patient testing, the incidence and relevance of pre-operative anaemia, anaemia management in obstetrics, pre-operative anaemia in orthopaedics, haemostatic sealants, the effect of transfusion in cardiovascular surgery, transfusion alternatives.

    1 in stock

    £27.00

  • Biotechnology of Blood Proteins: Purification,

    John Libbey Eurotext Biotechnology of Blood Proteins: Purification,

    1 in stock

    Book SynopsisThere are today five major proteins in plasma fractioning. In the near future, other fractions could also be used as therapeutic agents. But perhaps they could be used for alternative, non-therapeutic applications? For example, producing human culture media with specific ingredients for biotechnology research might also be of use. Whatever the future may hold, there is one essential question: in today''s world of cellular and genetic engineering, are extracted therapeutic proteins still of any relevance? For a clear and up-to-date view of recent developments in blood-protein-separation technology, this book will prove an invaluable resource.

    1 in stock

    £62.89

  • Transfusion Medicine: The French Model

    John Libbey Eurotext Transfusion Medicine: The French Model

    4 in stock

    Book SynopsisText in French.

    4 in stock

    £36.54

  • Springer Handbook of Hematologic and Oncologic Emergencies

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £170.99

  • Springer ANCAAssociated Vasculitides

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £237.49

  • 15 in stock

    £109.50

  • Springer Comparative Hemostasis in Vertebrates

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £170.99

  • Springer Gene Therapy of Cancer

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £237.49

  • Springer Drug Resistance in Leukemia and Lymphoma III

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £170.99

  • Springer Plasminogen Structure Activation and Regulation

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £85.49

  • Springer Immunobiology of Organ Transplantation

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £284.99

  • Springer Hematopoietic Stem Cell Transplantation

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £169.99

  • Springer Evidencebased Diagnosis A Handbook of Clinical Prediction Rules

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £85.49

  • Springer Chemistry of Iron

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £265.99

  • Springer Cancer Cell Lines Part 3 Leukemias and Lymphomas Human Cell Culture

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £170.99

  • 15 in stock

    £170.99

  • Springer Platelet Transfusion

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £44.99

  • 15 in stock

    £44.99

  • Springer Unresolved problems in Haemophilia

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £44.99

  • Springer Blood Viscosity Hyperviscosity and Hyperviscosaemia

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £237.49

  • Springer Enzyme Activation in BloodPerfused Artificial Organs 11 Developments in Hematology and Immunology

    15 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    15 in stock

    £170.99

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account